SEC Filings for INmune Bio Inc. (INMB)

$ 8.58   -0.35 (-3.92%) Volume: 65.18k 4:00 PM EST Nov 23, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)5411/12/2020
8-KCurrent report pursuant to Section 13 or 15(d)1711/09/2020
8-KCurrent report pursuant to Section 13 or 15(d)911/06/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)3811/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)1610/27/2020
8-KCurrent report pursuant to Section 13 or 15(d)510/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)210/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)3609/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)609/24/2020
8-KCurrent report pursuant to Section 13 or 15(d)509/17/2020
8-KCurrent report pursuant to Section 13 or 15(d)409/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)509/04/2020
8-KCurrent report pursuant to Section 13 or 15(d)509/03/2020
DEF 14AOther definitive proxy statements3108/21/2020
424B5Prospectus [Rule 424(b)(5)]908/19/2020
<<
First
<
Prev
12345678910111213